CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,090 enrolled
Drug / intervention
Adherence assessmentbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00028145
NCT00028145N/ACompleted

Perinatal Core Protocol

International Maternal Pediatric Adolescent AIDS Clinical Trials Group·observational·Posted Dec 14, 2001·Updated Oct 10, 2014

In Brief

An observational study evaluating Adherence assessment for HIV Infections and Pregnancy Complications, Infectious. Completed, enrolled 3,090 participants across 77 sites in 2 countries.

Detailed Summary

The purpose of this study is to collect and study clinical and laboratory information about a pregnant or new mother and her medical care that will increase our knowledge of the best care for HIV-infected pregnant women and their children. The rate of transmission of HIV from mothers to their infants has gone down. Specific U.S. Public Health Service guidelines recommend that HIV-infected pregnant women be treated with anti-HIV therapies; but the effectiveness of treatment and safety for the mother and her infant have not been fully examined. This study will monitor the health of women and their infants while they receive anti-HIV therapy. Also, this study will provide information that may be used for future studies.

Study Details

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 14, 2001
Enrollment StartOct 1, 2002
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10.7 yearsPosted 24.6 years ago

Interventions

Adherence assessmentbehavioral

Adherence will be assessed using questionnaires at all study visits.